European Joint Programme on Rare Diseases - Joint Transnational Call 2022


Canadian Institutes of Health Research (CIHR)  and European Commission


European Joint Programme on Rare Diseases - Joint Transnational Call 2022    

For More Information

An information webinar will be held on December 16, 8:30 am - 10:00 am EST [or 14.00-15.30 (CET)]. You will need to register for the webinar before end of day on Dec. 15.


Now launched! European Joint Programme on Rare Diseases - Joint Transnational Call 2022    

The Canadian Institutes of Health Research (CIHR) continues its long-standing collaboration with the European Commission by supporting an additional joint transnational call in 2021 and anticipates four more in 2022. 

The Canadian dedicated funding will support the involvement of Canadian researchers in multinational research consortia in the following areas: neurodegenerative diseases, rare diseases, and antimicrobial resistance. Read more about CIHR dedicated funding for European programs in key research areas.

For the area of rare-disease research, the CIHR Institute of Genetics, along with Ataxia Canada, and Le Fonds de recherche du Québec-Santé (FRQ-S) are pleased to announce their collaboration with the European Joint Programme on Rare Diseases to support a new funding opportunity:  

European Joint Programme on Rare Diseases (EJP RD) Joint Transnational Call 2022: Topic - the development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases. 

The call officially opened on  December 14, 2021 with a two-stage submission process: pre-proposal (Feb. 16, 2022), and full proposal (June 15, 2022). More information on the Joint Transnational Call 2022.

Note: an information webinar for this funding opportunity will be held on Dec. 16, 2021: 14.00-15.30 (CET). Registration for the webinar closes end of day on Dec. 15. For more details and how to register.

Special Notes

Please note that research activities carried out in the context of COVID-19 need to adhere to the University of Guelph COVID-19 research principles, policies, guidelines and processes as they may be updated from time to time and communicated on the Office of Research web-page.


If College-level review is required, your College will communicate its earlier internal deadlines.

Internal Deadline

Please submit your pre-proposal, along with an OR-5 Form to

External Deadline

Those invited to full application stage will work with the Office of Research Services around timelines for the review and submission of the full application documentation as required.

How to Apply

There will be a two-stage submission procedure for joint applications: pre-proposals and full proposals. 

An independent international Scientific Evaluation Committee will carry out a scientific evaluation according to specific evaluation criteria.

Date Notes

December 16, 2021

Information webinar for potential applicants

February 16, 2022

Pre-proposal submission deadline

End of April 2022

Invitation to full proposal

June 15, 2022

Full proposal submission deadline

July 28, 2022

Deadline for rebuttals

December 2022

Notification of funding decision

For Questions, please contact

For general questions regarding the joint call please contact the Joint Call Secretariat at the ISCIII, Spain:

Ignacio Baanante Balastegui
+34 91 822 25 76

Maria Druet
+34 91 822 2530

For questions regarding national eligibility criteria and requirements please contact the national contact:

Canadian Institutes of Health Research – Institute of Genetics (CIHR-IG)

Jennifer Vineham

 +1 343 552-2760

Alert Classifications
Funding Opportunities and Sponsor News

Health and Life Sciences